Generation of multiple replication-competent retroviruses through recombination between preXMRV-1 and preXMRV-2

Journal of Virology

Volumn 87, Issue 21, 2013, Pages 11525-11537

  Delviks Frankenberry, Krista ^a   Paprotka, Tobias ^a,d   Cingöz, Oya ^b,e   Wildt, Sheryl ^c   Hu, Wei Shau ^a   Coffin, John M ^b   Pathaka, Vinay K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c Harlan   (Switzerland)

^d GATC Biotech AG   (Germany)

^e College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POL PROTEIN; RNA DIRECTED DNA POLYMERASE; VIRUS DNA; VIRUS RNA;

5' UNTRANSLATED REGION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MOUSE; MURINE LEUKEMIA VIRUS; MURINE LEUKEMIA VIRUS 1; MURINE LEUKEMIA VIRUS 2; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROVIRUS; RETROVIRUS INFECTION; RNA TRANSCRIPTION; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TYPING;

ANIMAL STRUCTURES; ANIMALS; CELL LINE; CROSSES, GENETIC; DNA, VIRAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS; VIRUS REPLICATION; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

EID: 84886942453     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01787-13     Document Type: Article

References (52)

1. Cohen JC, Varmus HE. 1979. Endogenous mammary tumour virus DNA varies among wild mice and segregates during inbreeding. Nature 278: 418-423.
2. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, Brown DG, Brown SD, Bult C, Burton J, Butler J, Campbell RD, Carninci P, Cawley S, Chiaromonte F, Chinwalla AT, Church DM, Clamp M, Clee C, Collins FS, Cook LL, Copley RR, Coulson A, Couronne O, CuffJ, Curwen V, Cutts T, Daly M, David R, Davies J, Delehaunty KD, Deri J, Dermitzakis ET, et al. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature 420:520-562.
3. Stocking C, Kozak CA. 2008. Murine endogenous retroviruses. Cell. Mol. Life Sci. 65:3383-3398.
4. Maksakova IA, Romanish MT, Gagnier L, Dunn CA, van de Lagemaat LN, Mager DL. 2006. Retroviral elements and their hosts: insertional mutagenesis in the mouse germ line. PLoS Genet. 2:e2. doi:10.1371/journal.pgen.0020002.
5. Levy JA. 1973. Xenotropic viruses: murine leukemia viruses associated with NIH Swiss, NZB, and other mouse strains. Science 182:1151-1153.
6. Todaro GJ, Arnstein P, Parks WP, Lennette EH, Huebner RJ. 1973. A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum. Proc. Natl. Acad. Sci. U. S. A. 70:859-862.
7. Achong BG, Trumper PA, Giovanella BC. 1976. C-type virus particles in human tumours transplanted into nude mice. Br. J. Cancer 34:203-206.
8. Suzuki T, Yanagihara K, Yoshida K, Seido T, Kuga N. 1977. Infectious murine type-C viruses released from human cancer cells transplanted into nude mice. Gann 68:99-106.
9. Gautsch JW, Knowles AF, Jensen FC, Kaplan NO. 1980. Highly efficient induction of type C retroviruses by a human tumor in athymic mice. Proc. Natl. Acad. Sci. U. S. A. 77:2247-2250.
10. Ito YZ, Nakazato Y. 1984. A new serially transplantable human prostatic cancer (HONDA) in nude mice. J. Urol. 132:384-387.
11. Williams DK, Galvin TA, Ma H, Khan AS. 2011. Investigation of xenotropic murine leukemia virus-related virus (XMRV) in human and other cell lines. Biologicals 39:378-383.
12. Zhang YA, Maitra A, Hsieh JT, Rudin CM, Peacock CD, Karikari C, Brekken RA, Stastny V, Gao B, Girard L, Wistuba I, Frenkel E, Minna JD, Gazdar AF. 2011. Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts. Cancer Biol. Ther. 12:617-628.
13. Sfanos KS, Aloia AL, Hicks JL, Esopi DM, Steranka JP, Shao W, Sanchez-Martinez S, Yegnasubramanian S, Burns KH, Rein A, De Marzo AM. 2011. Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines. PLoS One 6:e20874. doi:10.1371/journal.pone.0020874.
14. Takeuchi Y, McClure MO, Pizzato M. 2008. Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. J. Virol. 82:12585-12588.
15. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL. 2006. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2:e25. doi:10.1371/journal.ppat.0020025.
16. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR. 2009. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc. Natl. Acad. Sci. U. S. A. 106: 16351-16356.
17. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA. 2009. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326:585-589.
18. Paprotka T, Delviks-Frankenberry KA, Cingoz O, Martinez A, Kung HJ, Tepper CG, Hu WS, Fivash MJ, Jr, Coffin JM, Pathak VK. 2011. Recombinant origin of the retrovirus XMRV. Science 333:97-101.
19. Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, Hackett J, Jr, Qiu X, Luk KC, Schochetman G, Knox A, Kogelnik AM, Levy JA. 2011. No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science 333:94-97.
20. Delviks-Frankenberry K, Cingoz O, Coffin JM, Pathak VK. 2012. Recombinant origin, contamination, and de-discovery of XMRV. Curr. Opin. Virol. 2:499-507.
21. Alter HJ, Mikovits JA, Switzer WM, Ruscetti FW, Lo SC, Klimas N, KomaroffAL, Montoya JG, Bateman L, Levine S, Peterson D, Levin B, Hanson MR, GenfiA, Bhat M, Zheng H, Wang R, Li B, Hung GC, Lee LL, SameroffS, Heneine W, Coffin J, Hornig M, Lipkin WI. 2012. A multicenter blinded analysis indicates no association between chronic fatigue syndrome/myalgic encephalomyelitis and either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus. mBio 3(5):e00266-12. doi:10.1128/mBio.00266-12.
22. Cingoz O, Paprotka T, Delviks-Frankenberry KA, Wildt S, Hu WS, Pathak VK, Coffin JM. 2012. Characterization, mapping, and distribution of the two XMRV parental proviruses. J. Virol. 86:328-338.
23. Knouf EC, Metzger MJ, Mitchell PS, Arroyo JD, Chevillet JR, Tewari M, Miller AD. 2009. Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J. Virol. 83:7353-7356.
24. Hue S, Gray ER, Gall A, Katzourakis A, Tan CP, Houldcroft CJ, McLaren S, Pillay D, Futreal A, Garson JA, Pybus OG, Kellam P, Towers GJ. 2010. Disease-associatedXMRVsequences are consistent with laboratory contamination. Retrovirology 7:111. doi:10.1186/1742-4690-7-111.
25. Katzourakis A, Hue S, Kellam P, Towers GJ. 2011. Phylogenetic analysis of murine leukemia virus sequences from longitudinally sampled chronic fatigue syndrome patients suggests PCR contamination rather than viral evolution. J. Virol. 85:10909-10913.
26. Smith RA. 2010. Contamination of clinical specimens with MLVencoding nucleic acids: implications for XMRV and other candidate human retroviruses. Retrovirology 7:112. doi:10.1186/1742-4690-7-112.
27. Oakes B, Tai AK, Cingoz O, Henefield MH, Levine S, Coffin JM, Huber BT. 2010. Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology 7:109. doi: 10.1186/1742-4690-7-109.
28. Robinson MJ, Erlwein OW, Kaye S, Weber J, Cingoz O, Patel A, Walker MM, Kim WJ, Uiprasertkul M, Coffin JM, McClure MO. 2010. Mouse DNA contamination in human tissue tested for XMRV. Retrovirology 7:108. doi:10.1186/1742-4690-7-108.
29. Sato E, Furuta RA, Miyazawa T. 2010. An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV. Retrovirology 7:110. doi:10.1186/1742-4690-7-110.
30. Tuke PW, Tettmar KI, Tamuri A, Stoye JP, Tedder RS. 2011. PCR master mixes harbour murine DNA sequences. Caveat emptor! PLoS One 6:e19953. doi:10.1371/journal.pone.0019953.
31. WolffD, Gerritzen A. 2011. Presence of murine leukemia virus (MLV)- related virus gene sequences in a commercial RT-PCR reagent. Clin. Lab. 57:631-634.
32. Zheng H, Jia H, Shankar A, Heneine W, Switzer WM. 2011. Detection of murine leukemia virus or mouse DNA in commercial RT-PCR reagents and human DNAs. PLoS One 6:e29050. doi:10.1371/journal.pone.0029050.
33. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, Collier D, Wessely S, Cleare A. 2010. Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 5:e8519. doi:10.1371/journal.pone.0008519.
34. Lee D, Das Gupta J, Gaughan C, Steffen I, Tang N, Luk KC, Qiu X, Urisman A, Fischer N, Molinaro R, Broz M, Schochetman G, Klein EA, Ganem D, Derisi JL, Simmons G, Hackett J, Jr, Silverman RH, Chiu CY. In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer. PLoS One 7:e44954. doi:10.1371/journal.pone.0044954.
35. Sharp PM, Hahn BH. 2011. Origins of HIV and the AIDS pandemic. Cold Spring Harb. Perspect. Med. 1:a006841. doi:10.1101/cshperspect.a006841.
36. Langdon SP. 2012. Animal modeling of cancer pathology and studying tumor response to therapy. Curr. Drug Targets 13:1535-1547.
37. Murgai M, Thomas J, Cherepanova O, Delviks-Frankenberry K, Deeble P, Pathak VK, Rekosh D, Owens G. 2013. Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels. Retrovirology 10:34. doi:10.1186/1742-4690-10-34.
38. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, Derisi JL, Chow SA, Silverman RH. 2007. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc. Natl. Acad. Sci. U. S. A. 104:1655-1660.
39. Chaipan C, Dilley KA, Paprotka T, Delviks-Frankenberry KA, Venkatachari NJ, Hu WS, Pathak VK. 2011. Severe restriction of xenotropic murine leukemia virus-related virus replication and spread in cultured human peripheral blood mononuclear cells. J. Virol. 85:4888-4897.
40. Overbergh L, Valckx D, Waer M, Mathieu C. 1999. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305-312.
41. Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks- Frankenberry KA, Hu WS, Pathak VK. 2010. Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J. Virol. 84:5719-5729.
42. Chesebro B, Britt W, Evans L, Wehrly K, Nishio J, Cloyd M. 1983. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus. Virology 127:134-148.
43. Alberts B, Dennis B, Lewis J, RaffM, Roberts K, Watson JD. 1994. Molecular biology of the cell, 3rd ed. Garland Publishing, Inc., New York, NY.
44. Hu WS, Temin HM. 1990. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc. Natl. Acad. Sci. U. S. A. 87:1556-1560.
45. Flynn JA, An W, King SR, Telesnitsky A. 2004. Nonrandom dimerization of murine leukemia virus genomic RNAs. J. Virol. 78:12129-12139.
46. Nikbakht KN, Ou CY, Boone LR, Glover PL, Yang WK. 1985. Nucleotide sequence analysis of endogenous murine leukemia virus-related proviral clones reveals primer-binding sites for glutamine tRNA. J. Virol. 54:889-893.
47. Colicelli J, GoffSP. 1986. Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J. Virol. 57:37-45.
48. Lund AH, Duch M, Lovmand J, Jorgensen P, Pedersen FS. 1993. Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication. J. Virol. 67:7125-7130.
49. Nitta T, Lee S, Ha D, Arias M, Kozak CA, Fan H. 2012. Moloney murine leukemia virus glyco-gag facilitates xenotropic murine leukemia virusrelated virus replication through human APOBEC3-independent mechanisms. Retrovirology 9:58. doi:10.1186/1742-4690-9-58.
50. Hibbert CS, Mirro J, Rein A. 2004. mRNA molecules containing murine leukemia virus packaging signals are encapsidated as dimers. J. Virol. 78: 10927-10938.
51. Rein A. 2011. Murine leukemia viruses: objects and organisms. Adv. Virol. 2011:403419. doi:10.1155/2011/403419.
52. Zhang WH, Svarovskaia ES, Barr R, Pathak VK. 2002. Y586F mutation in murine leukemia virus reverse transcriptase decreases fidelity of DNA synthesis in regions associated with adenine-thymine tracts. Proc. Natl. Acad. Sci. U. S. A. 99:10090-10095.